Related Experiment Video

Updated: May 29, 2026

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

MAGE-A family: attractive targets for cancer immunotherapy

Meixiang Sang1, Yishui Lian, Xinliang Zhou

  • 1Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.

Vaccine
|September 22, 2011
PubMed

Insights

Melanoma-associated antigen family A (MAGE-A) proteins are promising cancer immunotherapy targets due to their tumor-specific expression. Research explores MAGE-A

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Melanoma-associated antigen family A (MAGE-A) are cancer/testis antigens (CTA).
  • MAGE-A proteins are expressed in various tumors but not normal adult tissues (except testes).
  • Germ cells' lack of MHC class I antigen makes MAGE-A ideal immunotherapy targets.

Purpose of the Study:

  • To review MAGE-A expression and activation mechanisms in cancer.
  • To summarize MAGE-A's biological functions in cell progression.
  • To outline advancements in MAGE-A-targeted cancer immunotherapy.

Main Methods:

  • Literature review of MAGE-A expression and function.
  • Analysis of MAGE-A's role in cancer cell biology.
  • Summary of current MAGE-A-based immunotherapy strategies.

Main Results:

  • MAGE-A proteins exhibit restricted expression patterns, making them suitable for targeted therapies.
  • MAGE-A plays roles in cell cycle regulation and proliferation.
  • Several MAGE-A proteins are being investigated in ongoing immunotherapy trials.

Conclusions:

  • MAGE-A family represents a significant target for novel cancer immunotherapies.
  • Understanding MAGE-A expression and function is crucial for developing effective treatments.
  • Targeting MAGE-A holds promise for improving patient outcomes in various cancers.

More Related Videos

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...